Feasibility study of ADCs targeting TROP-2, HER2, and CD46 in Ductal Adenocarcinoma and Intraductal Carcinoma of the prostate-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Feasibility study of ADCs targeting TROP-2, HER2, and CD46 in Ductal Adenocarcinoma and Intraductal Carcinoma of the prostate

Published:2024-07-11 Issue:1 Volume:42 Page:
ISSN:1433-8726
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Wang Xingming,Qi Lin,Chen Minfeng,Zhang Ye,Gao Xiaomei,Cai Yi

Funder

Key Research and Development Program of Hunan Province of China

National Natural Science Foundation of China

Clinical Research Foundation of the National Clinical Research Center for Geriatric Diseases

Outstanding Youth Fund Project of Hunan Province

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00345-024-05109-8.pdf

Reference30 articles.

1. Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209

2. Ranasinghe W, Shapiro DD, Zhang M et al (2021) Optimizing the diagnosis and management of ductal prostate cancer. Nat Rev Urol 18:337

3. Porter LH, Lawrence MG, Ilic D et al (2017) Systematic review links the prevalence of intraductal carcinoma of the prostate to prostate cancer risk categories. Eur Urol 72:492

4. Jang WS, Shin SJ, Yoon CY et al (2017) Prognostic significance of the proportion of Ductal Component in Ductal Adenocarcinoma of the prostate. J Urol 197:1048

5. Harkin T, Elhage O, Chandra A et al (2019) High ductal proportion predicts biochemical recurrence in prostatic ductal adenocarcinoma. BJU Int 124:907

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP